வேன் மானென் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from வேன் மானென். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In வேன் மானென் Today - Breaking & Trending Today

NeRRe Therapeutics raises £20 million in a Series B2


July
2021 – NeRRe Therapeutics, a clinical-stage company developing orvepitant, its wholly-owned neurokinin-1 (NK-1) antagonist, as a first in class treatment for disabling chronic cough caused by reflex hypersensitivity disorders, today announces it has raised an additional £20 million in a Series B2 financing round.
Having demonstrated proof of efficacy in patients with refractory or unexplained chronic cough
i, NeRRe will now continue the clinical development of orvepitant in chronic cough caused by IPF, a rare type of interstitial lung disease
ii. A dominant symptom of this severe progressive fibrotic pulmonary disease, in a high proportion of these terminally ill patients, is an uncontrolled, persistent, and disabling cough. ....

New York , United States , Hong Kong , United Kingdom , San Francisco , University Of Southern California , Trowerm Pawsey , Los Angeles , Mary Kerr , Javier Garcia , Advent Life Sciences , United Kingdom Government Future Fund , European Recovery Programme , British Business Bank , Dutch Venture Initiative , Consilium Strategic Communications , Columbus Venture Partners , Fountain Healthcare Partners , Forbion Capital Partners , United Kingdom Government , Maher Professor , Interstitial Lung Disease , Keck School , Southern California , General Partner , Venture Partners ,